Late complications of chronic respiratory infections in patients with common variable immunodeficiency
Authors:
O. Kopecký 1; Š. Lukešová 1; V. Koblížek 3; V. Vroblová 1; J. Novotný 2
Authors‘ workplace:
Ústav klinické imunologie a alergologie Lékařské fakulty UK a FN Hradec Králové, přednosta MUDr. Otakar Kopecký, CSc.
1; Radiologická klinika Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MUDr. Pavel Eliáš, CSc.
2; Plicní klinika Lékařské fakulty UK a FN Hradec Králové, přednosta doc. MUDr. František Salajka, CSc.
3
Published in:
Vnitř Lék 2006; 52(11): 1021-1029
Category:
Original Contributions
Overview
Common variable immunodeficiency (CVID) is the most frequent serious humoral deficiency manifested in adulthood, and is due to acute and chronic respiratory infections which lead to respiratory failure. Retrospective analyses of 28 CVID patients were made. Mean age at time of diagnosis was 38.6 ± 18.6 years. The development of the first symptoms to the time of diagnosis was delayed 14.1 ± 10.2 years, three times longer than in other studies. Twenty-three (82.1 %) of the patients had respiratory complications. Chronic obstructive pulmonary diseases, n = 16 (57.1 %), and bronchiectasis, n = 10 (35.7 %), were the most frequent types of lung damage. In addition, two patients (7.1 %) had evidence of an interstitial lung process. The morbidity associated with CVID may be reduced by early diagnosis and adequate dosage of immunoglobulins to minimalize the occurrence and progression of lung damage.
Key words:
bronchiectasis - interstitial lung - fibrosis - antibody deficiency - common variable immunodeficiency - lung damage
Sources
1. Aukrust P, Lien E, Kristoffersen AK et al. Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency - possible immunologic and clinical consequences. Blood 1996; 87: 674-681.
2. Bjoraker JA, Ryu JH, Edwin MK et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157: 199-203.
3. Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002; 109: 1001-1004.
4. Cadranel J, Bouvry D, Wislez M. Respiratory manifestations of common variable immunodeficiency in adults. Rev Mal Respir 2003; 20: 126-133.
5. Cunningham-Rundles C. Clinical and immunologic analyses of 103 patients with common variable immune deficiency. J Clin Immunol 1989; 9: 22-33.
6. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immun 1999; 92: 34-48.
7. de Gracia J, Vendrell M, Álvarez A. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. International Immunopharmacol 2004; 4: 745-753.
8. Grimbacher B, Hutloff A, Schlesier M et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003; 4: 261-268
9. Hammarström L 2nd, Vorechovsky I, Webster D. Selective IgA deficiency (sIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000; 120: 225-231.
10. Homolka J. Idiopathic pulmonary fibrosis: adverse prognosis in artificial respiration patients. Pneumologie 2002; 56: 161-162.
11. Hutloff A, Bücher K, Reiter K et al. Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus. Arthritis Rheum 2004; 50: 3211-3220.
12. Kainulainen L, Nikoskelainen J, Ruuskanen O. Diagnostic findings in 95 finnish patients with common variable immunodeficiency. J Clin Immunol 2001; 21: 145-149.
13. Kainulainen L, Nikoskelainen J, Vuorinen T et al. Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia. Am J Respir Crit Care Med 1999; 159: 1199-1204.
14. Kainulainen L, Varpula M, Liippo K et al. Pulmonary abnormalities in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol 1999; 104: 1031-1036.
15. Ko J, Radigan L, Cunningham-Rundles C. Switched memory B cells in common variable immunodeficiency. J Allergy Clin Immunol 2004; 113 (Suppl 1): S38.
16. Kokron CM, Errante PR, Barros MT et al. Clinical and laboratory aspects of common variable immunodeficiency. An Acad Bras Cienc 2004; 76: 707-726.
17. Lamari F, Karamanos NK, Papadopoulou-Alataki E et al. Monitoring of two intravenous immunoglobulin preparations for immunoglobulin G subclasses and specific antibodies to bacterial surface antigens and relation with their levels in treated immunodeficient patients. J Pharmaceut Biomed Analysis 2000; 22: 1029-1036.
18. Litzman J, Burianova M, Thon V et al. Progression of selective IgA deficiency to common variable immunodeficiency in a 16 year old boy. Allergol Immunopathol (Madr) 1996; 24: 174-176.
19. Losi CG, Silini A, Fiorini C et al. Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency. J Clin Immunol 2005; 25: 496-502.
20. Popa V, Colby TV, Reich SB. Pulmonary interstitial disease in Ig deficiency. Chest 2002; 122: 1594-1603.
21. Salzer U, Chapel HM, Webster ADB et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nature Gen 2005; 37: 820-828.
22. Salzer U, Grimbacher B. TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity? New genetic defects in common variable immunodeficiency. Curr Opin Allergy Clin Immunol 2005; 5: 496-503.
23. Sewell WA, Buckland M, Jolles SR. Therapeutic strategies in common variable immunodeficiency. Drugs 2003; 63: 1359-1371.
24. Thickett KM, Kumararatne DS, Banerjee AK et al. Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. QJM 2002; 95: 655-662.
25. Thon V, Eggenbauer H, Wolf HM et al. Antigen presentation by common variable immunodeficiency (CVID) B cells and monocytes is unimpaired. Clin Exp Immunol 1997; 108: 1-8.
26. Wang Y, Carter RH CD19 regulates B cell maturation, proliferation, and positive selection in the FDC zone of murine splenic germinal centers. Immunity 2005; 22: 749-761.
27. Warnatz K, Denz A, Dräger R et al. Severe deficiency of switched memory B cells (CD27+IgM-IgD-) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002; 99: 1544-1551.
28. Webster AD Virus infections in primary immunodeficiency. J Clin Pathol 1994; 47: 965-967.
29. Webster DB Common variable immunodeficiency. Immunol Allergy Clin North Am 2001; 21: 1-22.
30. Weiler CR, Bankers-Fulbright JL Common variable immunodeficiency: test indications and interpretations. Mayo Clin Proc 2005; 80: 1187-1200.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2006 Issue 11
Most read in this issue
- Male hormonal contraception
- Transfusion-induced immunomodulation and infectious complications
- Mitral regurgitation: are we able to properly time the surgical procedure?
- Massive pulmonary embolism – attempt at embolectomy following the failure of thrombolytic treatment